Pillstats
Rx only · Tablet, Film Coated · Oral

Amlodipine Besylate Valsartan Hydrochlorothiazide

Brands: Amlodipine, Valsartan, Hydrochlorothiazide · Amlodipine Besylate + Hydrochlorothiazide + Valsartan

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)69749
US makers2 labelers
Packages20
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.27$4.55$6.82$9.09Dec 2025Apr 2026Jul 2026
$5.698
Latest avg · Jul 22, 2026
-28%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.1K4.3K6.4K8.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.4K
Rx · 2026 Q1
231K
Units dispensed
-39%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Strides Pharma Science Limitedunknown15SUPPLYING
Golden State Medical Supply, Inc.unknown5SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.